NCT05126459View on ClinicalTrials.gov

A Comparison of Oral Sedation-related Events of Three Multiagent Oral Sedation Regimens in Pediatric Dental Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

April 11, 2023

Study Completion Date

April 12, 2023

Conditions
Anxiety, DentalDental Decay
Interventions
COMBINATION_PRODUCT

Regimen 1

Administer orally after informed consent obtained prior to any dental procedure. Hydroxyzine (1.5- 2mg/kg) + Meperidine (1.5 -2 mg/kg) + Midazolam (0.5- 0.75 mg/kg) In combination with oral drugs stated above, administeration via inhalation of Nitrous oxide/oxygen (30-50% N2O/ 70-50% O2) via inhalation.

COMBINATION_PRODUCT

Regimen #2

Administer orally after informed consent obtained prior to any dental procedure. Hydroxyzine (1.5 - 2mg/kg) + Meperidine (1.5 -2 mg/kg). Administer Nitrous oxide/oxygen (30-50% N2O/ 70-50% O2) via inhalation.

COMBINATION_PRODUCT

Regimen #3

Administer orally after informed consent obtained prior to any dental procedure. Hydroxyzine (1.5 - 2mg/kg) + Midazolam (0.5- 0.75 mg/kg). Administer Nitrous oxide/oxygen (30-50% N2O/ 70-50% O2) via inhalation.

Trial Locations (1)

92354

Loma Linda University, Loma Linda

All Listed Sponsors
lead

Loma Linda University

OTHER